Medical Letter On Drugs And TherapeuticsSCIE

英文簡介Medical Letter On Drugs And Therapeutics期刊介紹

The Medical Letter, Inc. is committed to providing objective, practical, and timely information on drugs and treatments of common diseases to help our readers make the best decisions for their patients—without the influence of the pharmaceutical industry.

The Medical Letter On Drugs and Therapeutics is a biweekly publication that provides:

Evidence-based, peer-reviewed evaluations of new FDA-approved drugs with conclusions reached by a consensus of experts

New information on previously approved drugs including pivotal clinical trials, new indications, and safety warnings

Consensus recommendations for the preferred and alternative treatments for common disorders

Comparative reviews of drugs for a given indication with particular attention to clinical efficacy, adverse effects, drug interactions, and cost.

期刊簡介Medical Letter On Drugs And Therapeutics期刊介紹

《Medical Letter On Drugs And Therapeutics》自1959出版以來，是一本醫學優秀雜志。致力于發表原創科學研究結果，并為醫學各個領域的原創研究提供一個展示平臺，以促進醫學領域的的進步。該刊鼓勵先進的、清晰的闡述，從廣泛的視角提供當前感興趣的研究主題的新見解，或審查多年來某個重要領域的所有重要發展。該期刊特色在于及時報道醫學領域的最新進展和新發現新突破等。該刊近一年未被列入預警期刊名單，目前已被權威數據庫SCIE收錄，得到了廣泛的認可。

該期刊投稿重要關注點：

• 預計審稿時間： 較慢,6-12周
• 醫學
• PHARMACOLOGY & PHARMACY
• SCIE
• 中科院4區
• 非預警